AIDS and cancer are high-frequency NEET topics where terminology traps cost marks. The common trap: confusing which test screens for HIV versus which confirms it — and mixing up what CD4+ T cell count actually tells a clinician.
AIDS — the biology. HIV (Human Immunodeficiency Virus) is a retrovirus that selectively destroys helper T lymphocytes (CD4+ T cells). Transmission occurs through sexual contact, contaminated blood/needles, and from infected mother to child (transplacental or through breast milk). HIV is NOT transmitted by touch, mosquito bites, or sharing food (NCERT Class 12 Biology Chapter 7, page 164).
The diagnostic sequence matters. ELISA (Enzyme-Linked Immunosorbent Assay) is the screening test — it is cheap, sensitive, and used first. A positive ELISA alone does not confirm HIV. Western blot is the confirmatory test. CD4+ T cell count is neither screening nor confirmatory — it monitors disease progression. When CD4+ count drops below 200 cells/µL, the condition is classified as AIDS.
Cancer — key facts. Cancer results from uncontrolled cell division caused by activation of oncogenes or inactivation of tumour suppressor genes. Benign tumours remain localised; malignant tumours (cancers) show metastasis — spread to distant sites via blood and lymph. Carcinogens include physical agents (UV, X-rays), chemical agents (tobacco smoke compounds), and biological agents (oncogenic viruses).
Prevention and detection. Cancer detection methods include biopsy, radiography, CT, MRI, and molecular markers. AIDS prevention centres on safe practices, screening of blood before transfusion, use of disposable needles, and public awareness — no vaccine is available for HIV as of the NCERT syllabus.
Watch out: NEET questions on AIDS frequently test the ELISA-vs-Western-blot-vs-CD4 distinction. Read the stem carefully for whether it asks about screening, confirmation, or monitoring — each maps to a different answer.